| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Cheng-Kai Huang, Jay Wu, Kai-Yuan Cheng, Lung-Kwang Pa. Optimization of imaging parameters for SPECT scans of [99mTc]TRODAT-1 using Taguchi analysis. PloS one. vol 10. issue 3. 2016-02-04. PMID:25790100. |
parkinson's disease (pd) is a neurodegenerative disease characterized by progressive loss of dopaminergic neurons in the basal ganglia. |
2016-02-04 |
2023-08-13 |
human |
| Neda Masoudi, Pablo Ibanez-Cruceyra, Sarah-Lena Offenburger, Alexander Holmes, Anton Gartne. Tetraspanin (TSP-17) protects dopaminergic neurons against 6-OHDA-induced neurodegeneration in C. elegans. PLoS genetics. vol 10. issue 12. 2016-01-29. PMID:25474638. |
parkinson's disease (pd), the second most prevalent neurodegenerative disease after alzheimer's disease, is linked to the gradual loss of dopaminergic neurons in the substantia nigra. |
2016-01-29 |
2023-08-13 |
caenorhabditis_elegans |
| M Tuppy, B F Barna, L Alves-Dos-Santos, L R G Britto, S Chiavegatto, T S Moreira, A C Takakur. Respiratory deficits in a rat model of Parkinson's disease. Neuroscience. vol 297. 2016-01-27. PMID:25838118. |
parkinson's disease (pd) is a neurodegenerative disease characterized by loss of the dopaminergic nigrostriatal pathway. |
2016-01-27 |
2023-08-13 |
rat |
| Sambuddha Basu, Goun Je, Yoon-Seong Ki. Transcriptional mutagenesis by 8-oxodG in α-synuclein aggregation and the pathogenesis of Parkinson's disease. Experimental & molecular medicine. vol 47. 2016-01-26. PMID:26315598. |
parkinson's disease (pd) is an age-related progressive neurodegenerative disease associated with selective loss of dopaminergic neurons. |
2016-01-26 |
2023-08-13 |
Not clear |
| Patricia Giuliani, Patrizia Ballerini, Silvana Buccella, Renata Ciccarelli, Michel P Rathbone, Silvia Romano, Iolanda D'Alimonte, Francesco Caciagli, Patrizia Di Iorio, Mieczyslaw Pokorsk. Guanosine protects glial cells against 6-hydroxydopamine toxicity. Advances in experimental medicine and biology. vol 837. 2015-12-14. PMID:25310956. |
increasing body of evidence indicates that neuron-neuroglia interaction may play a key role in determining the progression of neurodegenerative diseases including parkinson's disease (pd), a chronic pathological condition characterized by selective loss of dopaminergic (da) neurons in the substantia nigra. |
2015-12-14 |
2023-08-13 |
rat |
| Lei Liu, Carina Peritore, Jessica Ginsberg, Merve Kayhan, Gizem Donme. SIRT3 attenuates MPTP-induced nigrostriatal degeneration via enhancing mitochondrial antioxidant capacity. Neurochemical research. vol 40. issue 3. 2015-12-04. PMID:25555707. |
parkinson's disease (pd) is one of the most common neurodegenerative diseases, which is characterized by progressive degeneration of nigrostriatal dopaminergic neurons. |
2015-12-04 |
2023-08-13 |
mouse |
| Zhiguo Che. Cell Therapy for Parkinson's Disease: New Hope from Reprogramming Technologies. Aging and disease. vol 6. issue 6. 2015-11-30. PMID:26618051. |
parkinson's disease (pd) is a neurodegenerative disease with the major pathology being the progressive loss of dopaminergic (da) midbrain neurons in the substantia nigra. |
2015-11-30 |
2023-08-13 |
Not clear |
| Yujeong Lee, Hee Ra Park, Hye Jeong Chun, Jaewon Le. Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease via mitochondrial stabilization. Journal of neuroscience research. vol 93. issue 5. 2015-11-25. PMID:25677261. |
parkinson's disease (pd) is a progressive neurodegenerative disease characterized by the selective loss of dopaminergic neurons in the nigrostriatal pathway. |
2015-11-25 |
2023-08-13 |
mouse |
| Keisuke Kiriyama, Hirokazu Ohtaki, Natsuki Kobayashi, Norimitsu Murai, Minako Matsumoto, Shun Sasaki, Chika Sawa, Kazue Satoh, Masaji Matsunaga, Seiji Shiod. A nucleoprotein-enriched diet suppresses dopaminergic neuronal cell loss and motor deficit in mice with MPTP-induced Parkinson's disease. Journal of molecular neuroscience : MN. vol 55. issue 3. 2015-10-15. PMID:25303858. |
parkinson's disease (pd) is an obstinate progressive neurodegenerative disease and characterized by locomotor impairment and dopaminergic neuronal degeneration in the substantia nigra pars compacta (snc). |
2015-10-15 |
2023-08-13 |
mouse |
| Ji Ae Lee, Ji Hyun Kim, Seo Yeon Woo, Hyo Jin Son, Se Hee Han, Bo Ko Jang, Ji Won Choi, Dong Jin Kim, Ki Duk Park, Onyou Hwan. A novel compound VSC2 has anti-inflammatory and antioxidant properties in microglia and in Parkinson's disease animal model. British journal of pharmacology. vol 172. issue 4. 2015-09-29. PMID:25297649. |
neuroinflammation through microglial activation is involved in the pathogenesis of neurodegenerative diseases including parkinson's disease (pd), a major neurodegenerative disorder characterized by dopaminergic neuronal death in the substantia nigra. |
2015-09-29 |
2023-08-13 |
Not clear |
| Alicia M Pickrell, Chiu-Hui Huang, Scott R Kennedy, Alban Ordureau, Dionisia P Sideris, Jake G Hoekstra, J Wade Harper, Richard J Youl. Endogenous Parkin Preserves Dopaminergic Substantia Nigral Neurons following Mitochondrial DNA Mutagenic Stress. Neuron. vol 87. issue 2. 2015-09-28. PMID:26182419. |
parkinson's disease (pd) is a neurodegenerative disease caused by the loss of dopaminergic neurons in the substantia nigra. |
2015-09-28 |
2023-08-13 |
mouse |
| Kenneth K B Tan, Jason Y Tann, Sharvari R Sathe, Seok Hong Goh, Dongliang Ma, Eyleen L K Goh, Evelyn K F Yi. Enhanced differentiation of neural progenitor cells into neurons of the mesencephalic dopaminergic subtype on topographical patterns. Biomaterials. vol 43. 2015-09-21. PMID:25591959. |
parkinson's disease (pd) is a neurodegenerative disease attributed to the loss of midbrain dopaminergic (da) neurons. |
2015-09-21 |
2023-08-13 |
Not clear |
| Erin F Wolff, Levent Mutlu, Efi E Massasa, John D Elsworth, D Eugene Redmond, Hugh S Taylo. Endometrial stem cell transplantation in MPTP- exposed primates: an alternative cell source for treatment of Parkinson's disease. Journal of cellular and molecular medicine. vol 19. issue 1. 2015-08-31. PMID:25283241. |
parkinson's disease (pd) is a neurodegenerative disease caused by the loss of dopaminergic neurons in the substantia nigra. |
2015-08-31 |
2023-08-13 |
monkey |
| Roger Torrent, Francesca De Angelis Rigotti, Patrizia Dell'Era, Maurizio Memo, Angel Raya, Antonella Consigli. Using iPS Cells toward the Understanding of Parkinson's Disease. Journal of clinical medicine. vol 4. issue 4. 2015-08-04. PMID:26239346. |
parkinson's disease (pd) is the second most common age-related progressive neurodegenerative disease, which is mainly characterized by nigrostriatal dopaminergic (da) neuron degeneration and synaptic dysfunction. |
2015-08-04 |
2023-08-13 |
human |
| Natalie L Payne, Aude Sylvain, Carmel O'Brien, Daniella Herszfeld, Guizhi Sun, Claude C A Bernar. Application of human induced pluripotent stem cells for modeling and treating neurodegenerative diseases. New biotechnology. vol 32. issue 1. 2015-07-13. PMID:24815224. |
hipscs derived from patients with the neurodegenerative diseases amyotrophic lateral sclerosis, parkinson's disease, alzheimer's disease and multiple sclerosis have been successfully differentiated in vitro into disease-relevant cell types, including motor neurons, dopaminergic neurons and oligodendrocytes. |
2015-07-13 |
2023-08-13 |
human |
| Rukmini Mridula Kandadai, Shaik Afshan Jabeen, Meena A Kanikannan, Rupam Borgohai. Safinamide for the treatment of Parkinson's disease. Expert review of clinical pharmacology. vol 7. issue 6. 2015-06-15. PMID:25300164. |
parkinson's disease (pd) is a neurodegenerative disease caused by a complex interaction of loss of dopaminergic and non-dopaminergic neurotransmitter systems. |
2015-06-15 |
2023-08-13 |
Not clear |
| I A Prescott, L D Liu, J O Dostrovsky, M Hodaie, A M Lozano, W D Hutchiso. Lack of depotentiation at basal ganglia output neurons in PD patients with levodopa-induced dyskinesia. Neurobiology of disease. vol 71. 2015-06-02. PMID:25116960. |
parkinson's disease (pd), characterized by the loss of dopaminergic nigrostriatal projections, is a debilitating neurodegenerative disease which produces bradykinesia, rigidity, tremor and postural instability. |
2015-06-02 |
2023-08-13 |
Not clear |
| Andrew Agbay, Nima Khadem Mohtaram, Stephanie Michelle Willert. Controlled release of glial cell line-derived neurotrophic factor from poly(ε-caprolactone) microspheres. Drug delivery and translational research. vol 4. issue 2. 2015-05-08. PMID:25786730. |
glial cell line-derived neurotrophic factor (gdnf), a growth factor expressed in the central nervous system, promotes the survival of both dopaminergic and motor neurons, making it a promising candidate for neurodegenerative disease therapy. |
2015-05-08 |
2023-08-13 |
cattle |
| Bo M Morberg, Joakim Jensen, Matthias Bode, Lene Wermut. The impact of high intensity physical training on motor and non-motor symptoms in patients with Parkinson's disease (PIP): a preliminary study. NeuroRehabilitation. vol 35. issue 2. 2015-04-17. PMID:24990028. |
parkinson's disease (pd) is a neurodegenerative disease caused by loss of dopaminergic nigrostriatal neurons. |
2015-04-17 |
2023-08-13 |
Not clear |
| Sandra A Acosta, Naoki Tajiri, Ike de la Pena, Marina Bastawrous, Paul R Sanberg, Yuji Kaneko, Cesar V Borlonga. Alpha-synuclein as a pathological link between chronic traumatic brain injury and Parkinson's disease. Journal of cellular physiology. vol 230. issue 5. 2015-04-10. PMID:25251017. |
notably, tbi may predispose long-term survivors to age-related neurodegenerative diseases, such as parkinson's disease (pd), which is characterized by a gradual degeneration of the nigrostriatal dopaminergic neurons. |
2015-04-10 |
2023-08-13 |
rat |